John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Everspin Technologies
MRAM
$428M
| $394K | ﹤0.01% |
77,288
-37,629
| -33% | -$218K |
|
2552
ALPS Dynamic US Dividend Advantage ETF
RFDA
$83.2M
| $393K | ﹤0.01% |
7,400
| – | – |
|
2553
Safe Bulkers
SB
$887M
| $391K | ﹤0.01% |
105,947
-54,239
| -34% | -$198K |
|
2554
Personalis
PSNL
$1.85B
| $387K | ﹤0.01% |
110,206
-35,456
| -24% | -$168K |
|
2555
ChargePoint
CHPT
$153M
| $386K | ﹤0.01% |
31,936
+27,321
| +592% | +$455K |
|
2556
Karat Packaging
KRT
$972M
| $386K | ﹤0.01% |
14,519
-1,339
| -8% | -$39.9K |
|
2557
PMV Pharmaceuticals
PMVP
$69.5M
| $385K | ﹤0.01% |
353,227
-153,759
| -30% | -$209K |
|
2558
A.O. Smith
AOS
$8.43B
| $383K | ﹤0.01% |
+5,855
| New | +$396K |
|
2559
Hilton Grand Vacations
HGV
$3.49B
| $382K | ﹤0.01% |
10,218
-7,915
| -44% | -$316K |
|
|
NREF
2560
NexPoint Real Estate Finance
NREF
$326M
| $381K | ﹤0.01% |
24,947
+11,568
| +86% | +$181K |
|
2561
Bank7 Corp
BSVN
$496M
| $381K | ﹤0.01% |
+9,837
| New | +$411K |
|
|
BTM
2562
DELISTED
Bitcoin Depot
BTM
| $379K | ﹤0.01% |
35,901
-1,772
| -5% | -$18K |
|
2563
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.83B
| $378K | ﹤0.01% |
+4,900
| New | +$395K |
|
2564
Resources Connection
RGP
$147M
| $375K | ﹤0.01% |
57,348
-173,236
| -75% | -$1.34M |
|
2565
Trustmark
TRMK
$2.68B
| $375K | ﹤0.01% |
+10,860
| New | +$388K |
|
2566
Adicet Bio
ACET
$84.3M
| $374K | ﹤0.01% |
30,936
-13,024
| -30% | -$186K |
|
2567
Pliant Therapeutics
PLRX
$71.8M
| $372K | ﹤0.01% |
275,287
+178,209
| +184% | +$1.08M |
|
2568
NETGEAR
NTGR
$578M
| $372K | ﹤0.01% |
15,191
-45,593
| -75% | -$1.2M |
|
2569
Silicom
SILC
$243M
| $371K | ﹤0.01% |
24,921
-1,002
| -4% | -$16.3K |
|
2570
AXT Inc
AXTI
$4.39B
| $371K | ﹤0.01% |
262,781
-301,644
| -53% | -$576K |
|
|
STR
2571
DELISTED
Sitio Royalties
STR
| $370K | ﹤0.01% |
18,598
-48,909
| -72% | -$990K |
|
2572
Trinity Industries
TRN
$2.35B
| $367K | ﹤0.01% |
+13,082
| New | +$439K |
|
2573
Stagwell
STGW
$2.13B
| $367K | ﹤0.01% |
+60,643
| New | +$381K |
|
|
EVRI
2574
DELISTED
Everi Holdings
EVRI
| $363K | ﹤0.01% |
26,591
-75,846
| -74% | -$1.04M |
|
2575
Fox Factory Holding Corp
FOXF
$891M
| $363K | ﹤0.01% |
15,567
-134,511
| -90% | -$3.6M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.